BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32977999)

  • 21. DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.
    Wang S; Hou P; Pan W; He W; He DC; Wang H; He H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.
    Liu YG; Jin SW; Zhang SS; Xia TJ; Liao YH; Pan RL; Yan MZ; Chang Q
    Front Immunol; 2024; 15():1338096. PubMed ID: 38495892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity.
    Zhou P; Cowled C; Todd S; Crameri G; Virtue ER; Marsh GA; Klein R; Shi Z; Wang LF; Baker ML
    J Immunol; 2011 Mar; 186(5):3138-47. PubMed ID: 21278349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chicken IFN Kappa: A Novel Cytokine with Antiviral Activities.
    Santhakumar D; Iqbal M; Nair V; Munir M
    Sci Rep; 2017 Jun; 7(1):2719. PubMed ID: 28578423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in understanding viral evasion of type I interferon.
    Taylor KE; Mossman KL
    Immunology; 2013 Mar; 138(3):190-7. PubMed ID: 23173987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Regulation of Type I and Type III Interferon Signaling.
    Stanifer ML; Pervolaraki K; Boulant S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interferon antiviral response: from viral invasion to evasion.
    Grandvaux N; tenOever BR; Servant MJ; Hiscott J
    Curr Opin Infect Dis; 2002 Jun; 15(3):259-67. PubMed ID: 12015460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells.
    Pervolaraki K; Guo C; Albrecht D; Boulant S; Stanifer ML
    J Interferon Cytokine Res; 2019 Oct; 39(10):650-660. PubMed ID: 31199715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons.
    Dang W; Xu L; Yin Y; Chen S; Wang W; Hakim MS; Chang KO; Peppelenbosch MP; Pan Q
    Antiviral Res; 2018 Jul; 155():48-59. PubMed ID: 29753657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression and activity of the porcine type I interferon family.
    Sang Y; Rowland RR; Hesse RA; Blecha F
    Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I IFN family members: similarity, differences and interaction.
    Capobianchi MR; Uleri E; Caglioti C; Dolei A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):103-11. PubMed ID: 25466633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The first answer to viral infections: type I interferon].
    Pichlmair A; Pollak M; Bergthaler A
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpesviruses and the Type III Interferon System.
    Yin Y; Favoreel HW
    Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel plant-derived recombinant human interferons with broad spectrum antiviral activity.
    Koehler JW; Dupuy LC; Garrison AR; Beitzel BF; Richards MJ; Ripoll DR; Wallqvist A; Teh SY; Vaewhongs AA; Vojdani FS; Padgett HS; Schmaljohn CS
    Antiviral Res; 2011 Dec; 92(3):461-9. PubMed ID: 22020161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Cycle Arrest in G
    Bressy C; Droby GN; Maldonado BD; Steuerwald N; Grdzelishvili VZ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon down-regulation of miR-1225-3p as an antiviral mechanism through modulating Grb2-associated binding protein 3 expression.
    Cheng M; Niu Y; Fan J; Chi X; Liu X; Yang W
    J Biol Chem; 2018 Apr; 293(16):5975-5986. PubMed ID: 29496996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferons and viruses: signaling for supremacy.
    Galligan CL; Murooka TT; Rahbar R; Baig E; Majchrzak-Kita B; Fish EN
    Immunol Res; 2006; 35(1-2):27-40. PubMed ID: 17003507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.